Latest Distribution News

Sparc Technologies has signed a non-exclusive MoU with UK graphene producer Levidian Nanosystems to develop and commercialise ecosparc-enhanced coatings across the GCC. The agreement sets targets for a binding commercial deal within 12 months and potential UAE manufacturing within 24 months, but commits neither sales nor revenue.

HMC Capital delivered FY26 operating earnings in line with guidance while statutory results swung to a $111.6 million loss. The alternative asset manager is targeting at least 35 cents of underlying earnings per share and a 15 cents dividend in FY27.

Coventry Group’s Q1 FY27 EBITDA nearly doubled to A$5.4 million as cost reductions and margin gains began to outweigh modest sales growth. Leverage has also halved from its March peak, although the strategic review has yet to produce a transaction.

Resimac Group delivered a stronger FY26, with normalised NPAT up 26% to $49.9 million and total assets under management reaching a record $16.5 billion. The result supports higher ordinary dividends, but the lender is still managing asset finance run-off, ASIC hardship proceedings and longer-term funding risks.

Cue Energy delivered $19.8 million in operating cash flow and maintained its dividend in FY2026, despite lower profit, shrinking reserves and asset impairments. With Horizon Oil now controlling 57.03% of the register, the company enters FY2027 with a new board and an unusually busy drilling schedule.

Australian Vintage has returned to positive operating cash flow, but its FY26 statutory loss widened sharply after a $27 million inventory write-down and deferred tax charge. The wine group is betting that Poco Vino growth, further restructuring and lower stock levels can convert the cash improvement into debt reduction in FY27.

Vitura Health grew FY2026 revenue 6% to $131.2 million, but a sharp margin squeeze pushed the ASX-listed digital health company into a $4.4 million statutory loss. With ANZ debt classified as current and a potential $6 million FY2027 revenue hit from changed Bupa referrals, the promised turnaround faces a demanding test.

Firebrick Pharma has secured Philippine marketing approval for Nasodine Nasal Spray as an over-the-counter antiseptic, opening a potential launch in the 116 million-person market from early 2027. The approval remains subject to post-approval documentation and future revalidation.

Australian Finance Group used its 2026 AGM to highlight a stronger, less volume-dependent earnings base after statutory profit rose 39% in FY26. AFG Securities’ loan book has since reached $7.3 billion, while recent investments are expected to add $13 million to FY27 EBITDA under stated assumptions.

Charter Hall Long WALE REIT has maintained its FY27 operating earnings and distribution guidance at 25.5 cents per security after delivering 2% FY26 growth. A cheaper, longer-dated debt platform and a $6.1 billion portfolio give the REIT more financial flexibility, although the outlook still depends on execution and property valuations.

Warburg Pincus has refined its non-binding $5.25-per-security proposal for Ingenia, allowing securityholders to retain up to 5 cents of the next half-year distribution. The offer now hinges on exclusive due diligence and a board confirmation due by 19 October, but Ingenia has not endorsed it.

Benjamin Hornigold will pay shareholders a fully franked special dividend of 6.2 cents per share on 18 November, following litigation updates and executed deeds of settlement. The distribution is worth more than its headline cash amount to eligible Australian shareholders because it carries full franking credits.